In this study, based on network pharmacology, 50 compounds and 170 action targets of mSMG against IR in T2DM were screened, and 9 hub targets such as TNF (encodes TNF-α protein) and MAPK8 (encodes JNK1 protein) were identified. The gene discussed is MAPK8; the disease is type 2 diabetes mellitus.